UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risk factors for low bone mass in healthy 40-60 year old women: A systematic review of the literature

Osteoporosis international, 2009-01, Vol.20 (1), p.1-21

2009

Volltextzugriff (PDF)

Trabecular bone score in kidney transplant recipients

Osteoporosis international, 2016-03, Vol.27 (3), p.1115-1121

2016

Volltextzugriff (PDF)

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

The New England journal of medicine, 2001-05, Vol.344 (19), p.1434-1441

2001

Volltextzugriff (PDF)

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

The journal of clinical endocrinology and metabolism, 2000-06, Vol.85 (6), p.2129-2134

2000

Volltextzugriff (PDF)

Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis

Bone (New York, N.Y.), 2000-08, Vol.27 (2), p.311-318

2000

Volltextzugriff (PDF)

Nuclear Localization of the Type 1 PTH/PTHrP Receptor in Rat Tissues

Journal of bone and mineral research, 2000-06, Vol.15 (6), p.1033-1044

2000

Volltextzugriff (PDF)

A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone Versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis

The journal of clinical endocrinology and metabolism, 1997-02, Vol.82 (2), p.620-628

1997

Volltextzugriff (PDF)

Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation

Bone (New York, N.Y.), 2000-03, Vol.26 (3), p.221-225

2000

Volltextzugriff (PDF)

An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis

The Journal of clinical investigation, 1993-03, Vol.91 (3), p.1138-1148

1993

Volltextzugriff (PDF)

Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use

Endocrine reviews, 2005-08, Vol.26 (5), p.688-703

2005

Volltextzugriff (PDF)

Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma

Journal of allergy and clinical immunology, 1995-08, Vol.96 (2), p.157-166

1995

Volltextzugriff (PDF)

Management of corticosteroid-induced osteoporosis

Seminars in arthritis and rheumatism, 2000-02, Vol.29 (4), p.228-251

2000

Volltextzugriff (PDF)

Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: Evidence for de novo bone formation on quiescent cancellous surfaces

Bone (New York, N.Y.), 1993, Vol.14 (3), p.523-527

1993

Volltextzugriff (PDF)

Comparison of the biochemical responses to human parathyroid Hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans

The journal of clinical endocrinology and metabolism, 1999-08, Vol.84 (8), p.2739-2743

1999

Volltextzugriff (PDF)

The Addition of a Raloxifene Analog (LY117018) Allows for Reduced PTH(1–34) Dosing During Reversal of Osteopenia in Ovariectomized Rats

Journal of bone and mineral research, 1999-05, Vol.14 (5), p.675-679

1999

Volltextzugriff (PDF)

Enhanced osteoblast development after continuous infusion of hPTH(1-84) in the rat

Bone (New York, N.Y.), 1999-02, Vol.24 (2), p.89-94

1999

Volltextzugriff (PDF)

Rapid Small‐Animal Dual‐Energy X‐Ray Absorptiometry Using Digital Radiography

Journal of bone and mineral research, 2000-12, Vol.15 (12), p.2451-2457

2000

Volltextzugriff (PDF)

Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat

Bone (New York, N.Y.), 1999-05, Vol.24 (5), p.451-455

1999

Volltextzugriff (PDF)

A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man

The journal of clinical endocrinology and metabolism, 1992-08, Vol.75 (2), p.417-423

1992

Volltextzugriff (PDF)

Bone mineral measurement of phalanges: comparison of radiographic absorptiometry and area dual X-ray absorptiometry

Radiology, 2000-08, Vol.216 (2), p.586-591

2000

Volltextzugriff (PDF)

Comparison of the response of pelvic and proximal tibial cancellous bone in rat to ovariectomy with estrogen replacement

Bone (New York, N.Y.), 1998-09, Vol.23 (3), p.267-274

1998

Volltextzugriff (PDF)

Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis

Osteoporosis international, 2000-08, Vol.11 (7), p.607-614

2000

Volltextzugriff (PDF)

Occult infection and resistance of anaemia to rHuEpo therapy in renal failure

Nephrology, dialysis, transplantation, 1990, Vol.5 (3), p.232-234

1990

Volltextzugriff (PDF)

Evaluation of an Osteoporosis Self-Referral Program to Enhance Management Outcomes

Journal of clinical densitometry, 2004, Vol.7 (1), p.77-83

2004

Volltextzugriff (PDF)

Effects of dose and dosing schedule of inhaled budesonide on bone turnover

Journal of allergy and clinical immunology, 1991-10, Vol.88 (4), p.572-580

1991

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(148)

Publikationsform

Artikel
(181)
Berichte
(2)

Sprache

Englisch
(183)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(126)
Science & Technology
(126)
Humans
(118)
Female
(91)
Biological And Medical Sciences
(82)
Male
(68)
Middle Aged
(67)
Medical Sciences
(66)
Endocrinology & Metabolism
(48)
Aged
(46)
Adult
(41)
Osteoporosis
(37)
Pharmacology. Drug Treatments
(34)
Bone Density
(28)
Animals
(27)
Rats
(25)
Risk Factors
(20)
Fundamental And Applied Biological Sciences. Psychology
(19)
Bone Density - Drug Effects
(18)
Time Factors
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Risk factors for low bone mass in healthy 40-60 year old women: A systematic review of the literature

Trabecular bone score in kidney transplant recipients

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis

Nuclear Localization of the Type 1 PTH/PTHrP Receptor in Rat Tissues

A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone Versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis

Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation

An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis

Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use

Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma

Management of corticosteroid-induced osteoporosis

Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: Evidence for de novo bone formation on quiescent cancellous surfaces

Comparison of the biochemical responses to human parathyroid Hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans

The Addition of a Raloxifene Analog (LY117018) Allows for Reduced PTH(1–34) Dosing During Reversal of Osteopenia in Ovariectomized Rats

Enhanced osteoblast development after continuous infusion of hPTH(1-84) in the rat

Rapid Small‐Animal Dual‐Energy X‐Ray Absorptiometry Using Digital Radiography

Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat

A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man

Bone mineral measurement of phalanges: comparison of radiographic absorptiometry and area dual X-ray absorptiometry

Comparison of the response of pelvic and proximal tibial cancellous bone in rat to ovariectomy with estrogen replacement

Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis

Occult infection and resistance of anaemia to rHuEpo therapy in renal failure

Evaluation of an Osteoporosis Self-Referral Program to Enhance Management Outcomes

Effects of dose and dosing schedule of inhaled budesonide on bone turnover

Suchergebnisse filtern